50% of DOAC Doses are Inappropriate in Older Adults? On The Role of Appropriate Dosing
Anticoagulation Forum shared on LinkedIn:
”Did you know? Up to 50% of DOAC doses are inappropriate in older adults—with underdosing being more common than overdosing.
Underdosing can actually increase the risk of stroke, systemic embolism, and cardiovascular hospitalizations, without reducing bleed risk.
This new resource, Clinical Considerations: Anticoagulation Use in Older Adults, provides practical guidance on:
- Dosing best practices
- Managing fall risk
- Addressing modifiable bleeding risk factors
- Choosing the right anticoagulant through individualized, shared decision-making
Read the full resource here.
Then, test your knowledge with our Show You Know Quiz and see how your clinical decision-making stacks up.
This resource was made possible through our collaboration with the American Pharmacists Association (APhA), with support from an educational grant by the Bristol Myers Squibb and Pfizer Alliance.
Special thanks to our expert content developers and reviewers: Christina Bookwalter PharmD, MS MEd, BCPS, BCACP, Stacey Kaplon, PharmD, BCACP, Katie Meyer, PharmD, BCPS, BCGP, Amanda McFee Winans, PharmD, BCPS, CACP.”

Stay informed on the latets in the field of anticoagulation with Hemostasis Today.
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome
-
Sep 22, 2026, 08:18Salih Ehsan: Understanding the Major Glycoproteins on Platelets
-
Sep 22, 2026, 08:06Tim Brümmendorf: Exciting Sessions Ahead at ESHBMFS2026
-
Sep 22, 2026, 08:05Samin Mohsenian: Can Factor VII Activity Predict Bleeding Severity?
-
Sep 22, 2026, 07:59Cesar de Almeida Neto: Jehovah’s Witnesses Update Their Position on Blood Components
-
Sep 22, 2026, 07:39Better Trials and Better Treatments Through Greater Inclusion – American Society of Hematology
-
Sep 22, 2026, 07:18X. Long Zheng: From ADAMTS13 to New TTP Treatment